prenatal (before birth)

during birth

after birth

last normal menstrual period

estimated date of delivery

any pregnancy (regardless of duration), the number of pregnancies (including the one in progress)

a woman who has never been pregnant

a woman who is pregnant for the first time

a woman who has been pregnant before, regardless of the duration of the pregnancy

a woman who has given birth to one or more children who reached the age of viability (20 wk gestation), regardless of the number of fetuses delivered and whether those children are now living

a woman who has given to her first child (past the point of viability), regardless of whether the child was alive at birth or is now living

a woman who has given birth to two or more children (past the point of viability), regardless of whether the children were alive at birth or are presently alive

a woman who has not given birth to a child who reached the point of viability

termination of pregnancy before viability (20 wk gestation) either spontaneous or induced

prenatal age of the developing fetus calculated from the first day of the woman's LNMP

prenatal age of the developing fetus as calculated from the date of conception, approximately 2 wks less than the gestational age

a fetus that has reached the stage (usually at 20 wks) where it is capable of living outside of the uterus

In the TPMAL system, the number of term infants that were born (infants born after 37 wks of gestation) is represented by the ____.

In the TPMAL system, the number of preterm infants born (infants born after 20 wks or before 37 wks of gestation)is represented by the ____.

In the TPALM system, the number of pregnancies aborted before 20 wks of gestation (spontaneously or induced) is represented by the ____

In the TPALM system, the number of children now living is represented by the ____

In the TPALM system, the multiple birth number of multiple gestations is represented by the ____

A method of determining the EDD, after obtaining the first day of the last menstrual period, subtract 3 months and add 7 days

pregnancy is divided into three 13 wk parts

the cessation of menses

a yellow-brown pigmentation over the bridge of the nose and cheeks during pregnancy and in some women who are taking oral contraceptives. AKA the mask of pregnancy

fetal movement felt by the mother. First perceived at 16 to 20 wks of gestation

the softening of the cervix and the vagina caused by increased vascular congestion

the purplish of bluish discoloration of the cervix, vagina, and vulva caused by the increased vascular congestion.

softening of the lower uterine segment

because of Hegar's Sign, it is easy to flex the body of the uterus against the cervix

irregular, painless uterine contractions that begin in the second trimester.

benign tumors

a maneuver by which the fetal part is displaced by a light tap of the examining finger on the cervix, and then the part rebounds quickly.

may be identified by palpation after the 24th wk

stretch marks. Fine, pinkish white or purplish gray lines that some women develop when the elastic tissue has been stretched to its capacity

uses maternal urine or blood to determine the presence of hCG

human chorionic gonadotropin. A hormone produced early in pregnancy by the chorionic villi of the placenta

radioimmunoassay. A blood test that accurately identifies pregnancy as early as 1 wk after ovulation

may be detected as early as 10 wks of pregnancy by using a Doppler device

a soft blowing sound heard over the uterus during auscultation

a soft swishing sound heard as the blood passes through the umbilical cord vessels

produced by ovaries and placenta. Causes enlargement of breasts, uterus, and genitals

produced by corpus luteum and ovary and later by placenta. Maintains endometrium for implantation and inhibits uterine contractility

influences thyroid gland's size and activity and increases heart rate and metabolic rate 23% during pregnancy

human placental lactogen. AKA chorionic somatomammotropin. Produced by the placenta. Affects glucose and protein metabolism

melanocyte-stimulating hormone. Produced by anterior pituitary gland. causes pigmentation of skin to darken, resulting in brown patches on the face, dark line on abdomen, darkening of moles and freckles, and darkening of the nipples and areolae

produced by corpus luteum and placenta. Remodels collagen, causing connective tissue of symphysis pubis to be more movable and cervix to soften. Inhibits uterine activity

Produced by posterior pituitary gland. Stimulates uterine contraction. Inhibited by progesterone during pregnancy. After birth, helps keep uterus contracted. Stimulates milk ejection reflex during breastfeeding

thick mucus leads to the formation of a plug that seals the cervical canal

thinning and shortening of the cervix that occurs late in pregnancy and during labor

an expansion of the cervical os that allows passage of the fetus and products of conception

a small endocrine structure that develops inside a ruptured ovarian follicle and secretes both estrogen and progesterone

the part of the decidua that unites with the chorion to form the placenta. It is shed in lochial discharge after delivery

the organism that causes yeast infections

the process of producing and supplying breast milk

a secretion from the breast before the onset of true lactation. It has a high protein content, provides some immune properties, and cleanses the newborn's intestinal tract of mucus and meconium.

movement of the fetus and uterus downward into the pelvic cavity

AKA aortocaval compression. The lowering of blood pressure while in a supine position. Occurs as a result of pressure or the weight of the pregnant uterus on the inferior vena cava

AKA dilutional anemia. False anemia. Caused by the increase of plasma

heartburn

the number of years between the onset of menses and the date of conception

having mixed feelings or conflicting feelings about being pregnant

no risk demonstrated to the fetus in any trimester

This drug category causes no adverse effects in animals

This drug category causes is only prescribed after risks to the fetus are considered. Animal studies have shown adverse reaction

This drug category causes a definite fetal risk but may be given in spite of risks in life-threatening situations

This drug category causes absolute fetal abnormalities. Not to be used anytime during pregnancy